Articles that cite
this article:
A Peroxisome Proliferator-Activated Receptor γ Agonist Influenced Daily Profile of Energy Expenditure in Genetically Obese Diabetic Rats
Yuki Yoshida, Mineko Ichikawa, Minoru Ohta, Setsuko Kanai, Mikako Kobayashi, Yuhei Ichimaru, Takao Shimazoe, Shigenori Watanabe, Akihiro Funakoshi, Kyoko Miyasaka
Jpn J Pharmacol 88(3):279. [CrossRef]
Macronutrients and obesity: views, news and reviews
Lise Madsen, Bjørn Liaset, Karsten Kristiansen
Future Lipidol 3(1):43. [CrossRef]
Zukünftige Angriffspunkte für die Therapie des Typ-2-Diabetes
Harald Stingl, Michael Roden
Wien Klin Wochenschr 116(7-8):217. [CrossRef]
Current Therapeutic Drugs for Type 2 Diabetes, Still Useful After 50 Years?
George M. Hall, Grainne Nicholson
Anesth Analg 108(6):1727. [CrossRef]
Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients
A. Brunani, A. Caumo, S. Graci, G. Castagna, G. Viberti, A. Liuzzi
Diabetes Obes Metab 10(6):460. [CrossRef]
Islet-1: A Potentially Important Role for an Islet Cell Gene in Visceral Fat
Haiyan Li, Leonie K. Heilbronn, Dachun Hu, Ann M. Poynten, Miriam A. Blackburn, Deepali P. Shirkhedkar, Warren H. Kaplan, Adamandia D. Kriketos, Jiming Ye, Donald J. Chisholm
Obesity (Silver Spring) 16(2):356. [CrossRef]
Structural Development Studies of Subtype-Selective Ligands for Peroxisome Proliferator-Activated Receptors (PPARs) Based on the 3,4-Disubstituted Phenylpropanoic Acid Scaffold as a Versatile Template
Hiroyuki Miyachi, Yuichi Hashimoto
[CrossRef]
Hayato Ihara
26(2):47. [CrossRef]
A treatment for Mr WP: thiazolidinediones after troglitazone
C. T. Montague
Diabetic Med [CrossRef]
The Role of Insulin-Sensitizing Agents in the Treatment of Polycystic Ovary Syndrome
Niki Katsiki, Eleni Georgiadou, Apostolos I. Hatzitolios
Drug 69(11):1417. [CrossRef]
Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease
YouFei Guan, Matthew D Breyer
Kidney Int 60(1):14. [CrossRef]
Heterogeneity in the physiological states and pharmacological responses of differentiating 3T3-L1 preadipocytes
L.-H. Loo, H.-J. Lin, D. K. Singh, K. M. Lyons, S. J. Altschuler, L. F. Wu
j cell biol 187(3):375. [CrossRef]
Hemangiosarcoma in Rodents: Mode-of-Action Evaluation and Human Relevance
S. M. Cohen, R. D. Storer, K. A. Criswell, N. G. Doerrer, V. L. Dellarco, D. G. Pegg, Z. W. Wojcinski, D. E. Malarkey, A. C. Jacobs, J. E. Klaunig
Toxicol Sci 111(1):4. [CrossRef]
Adipocyte apoptosis in the regulation of body fat mass by leptin
Mary Anne Della-fera, Hao Qian, Clifton A. Baile
Diabetes Obes Metab 3(5):299. [CrossRef]
n-3 PUFA: bioavailability and modulation of adipose tissue function
Jan Kopecky, Martin Rossmeisl, Pavel Flachs, Ondrej Kuda, Petr Brauner, Zuzana Jilkova, Barbora Stankova, Eva Tvrzicka, Morten Bryhn
proc nutr soc 68(4):361. [CrossRef]
Comparison of adipose tissue changes following administration of rosiglitazone in the dog and rat
C. D. N. Toseland, S. Campbell, I. Francis, P. J. Bugelski, N. Mehdi
Diabetes Obes Metab 3(3):163. [CrossRef]
Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice
N. Maeda, A. Hiuge, T. Hibuse, K. Fujita, T. Okada, A. Hirata, S. Kihara, T. Funahashi, I. Shimomura
Cardiovasc Res 84(1):164. [CrossRef]
Activating Effect of Benzbromarone, a Uricosuric Drug, on Peroxisome Proliferator-Activated Receptors
Chiyoko Kunishima, Ikuo Inoue, Toshihiro Oikawa, Hiromu Nakajima, Tsugikazu Komoda, Shigehiro Katayama
[CrossRef]
Dietary Capsaicin Reduces Obesity-induced Insulin Resistance and Hepatic Steatosis in Obese Mice Fed a High-fat Diet
Ji-Hye Kang, Goto Tsuyoshi, In-Seob Han, Teruo Kawada, Young Min Kim, Rina Yu
Obesity (Silver Spring) [CrossRef]
Fad24 Causes Hyperplasia in Adipose Tissue and Improves Glucose Metabolism
Yoshikazu Johmura, Kayoko Watanabe, Keishi Kishimoto, Takashi Ueda, Shoichi Shimada, Shigehiro Osada, Makoto Nishizuka, Masayoshi Imagawa
Biol Pharm Bull 32(10):1656. [CrossRef]
The study of ginsenoside on PPARγ expression of mononuclear macrophage in type 2 diabetes
Hai-xiang Ni, Ning-juan Yu, Xue-hui Yang
Mol Biol Rep [CrossRef]
Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the treatment of Type 2 diabetes and atherosclerosis
Benoit Pourcet, Jean-Charles Fruchart, Bart Staels, Corine Glineur
eoed 11(3):379. [CrossRef]
PPARs, Obesity, and Inflammation
Sander Kersten, Rinke Stienstra, Caroline Duval, Michael Müller
[CrossRef]
Adipocytes
Todd Leff, James G. Granneman
[CrossRef]
Hexarelin Signaling to PPARγ in Metabolic Diseases
Annie Demers, Amélie Rodrigue-way, André Tremblay
[CrossRef]
Enhancing Effect of Troglitazone on Porcine Adipocyte Differentiation in Primary Culture: A Comparison with Dexamethasone
Yourka D. Tchoukalova, Dorothy B. Hausman, Roger G. Dean, Gary J. Hausman
Obesity (Silver Spring) 8(9):664. [CrossRef]
Role of the Adipocyte in Type 2 Diabetes
Stephen R. Farmer, Deepanwita Prusty
[CrossRef]
Thiazolidinediones as PPAR Agonists
Sunder Mudaliar, Robert R. Henry
[CrossRef]
Combination Therapy in Type 2 Diabetes
Mandeep Bajaj, Ralph A. Defronzo
[CrossRef]
Activation of PPARγ induces profound multilocularization of adipocytes in adult mouse white adipose tissues
Young Jun Koh, Byung-Hyun Park, Ji-Hyun Park, Jinah Han, In-Kyu Lee, Jin Woo Park, Gou Young Koh
Exp Mol Med 41(12):880. [CrossRef]
3T3-L1 adipocyte apoptosis induced by thiazolidinediones is peroxisome proliferator-activated receptor-γ-dependent and mediated by the caspase-3-dependent apoptotic pathway
Yuanyuan Xiao, Taichang Yuan, Wenqi Yao, Kan Liao
FEBS J 277(3):687. [CrossRef]
The anti-angiogenic herbal composition Ob-X inhibits adipose tissue growth in obese mice
M-Y Kim, B Y Park, H S Lee, E K Park, J C Hahm, J Lee, Y Hong, S Choi, D Park, H Lee
Int J Obes [CrossRef]
Curcumin stimulates glucose uptake through AMPK-p38 MAPK pathways in L6 myotube cells
Ji Man Park, Eung-Kyun Kim, Jung Ok Lee, Soo Kyung Lee, Jin Hee Jung, Ga Young You, Ji Hae Kim, Sun Hwa Park, Pann-Ghill Suh, Hyeon Soo Kim
J Cell Physiol [CrossRef]
Prolonged Decrease of Adipocyte Size after Rosiglitazone Treatment in High- and Low-Fat-Fed Rats**
Julia A. Johnson, Steven E. Trasino, Anthony W. Ferrante, Joseph R. Vasselli
Obesity (Silver Spring) 15(11):2653. [CrossRef]
Troglitazone reduces plasma levels of tumour necrosis factor-alpha in obese patients with type 2 diabetes
A. Katsuki, Y. Sumida, K. Murata, M. Furuta, R. Araki-sasaki, K. Tsuchihashi, Y. Hori, Y. Yano, E. C. Gabazza, Y. Adachi
Diabetes Obes Metab 2(3):189. [CrossRef]
Thiazolidinediones in the treatment of Type 2 diabetes
Andrew S Greenberg, Anastassios G Pittas
Expert Opin Pharmacother 3(5):529. [CrossRef]
Effects of telmisartan on fat distribution in individuals with the metabolic syndrome
Michio Shimabukuro, Hideaki Tanaka, Takeshi Shimabukuro
J Hypertens 25(4):841. [CrossRef]
Nuclear receptors in metabolic diseases
Ranjan Mukherjee, Jo Anne Saye, Peter R Young
eott 4(3):377. [CrossRef]
Chronic and acute effects of thiazolidinediones BM13.1258 and BM15.2054 on rat skeletal muscle glucose metabolism
C Fürnsinn, B Brunmair, M Meyer, S Neschen, R Furtmüller, M Roden, H F Kühnle, P Nowotny, B Schneider, W Waldhäusl
Br J Pharmacol 128(6):1141. [CrossRef]
Synthesis and PPAR-γ Ligand-Binding Activity of the New Series of 2′-Hydroxychalcone and Thiazolidinedione Derivatives
Sang Hoon Jung, Soo Young Park, Youngmi Kim-pak, Hong Kyu Lee, Kyong Soo Park, Kuk Hyun Shin, Kazuo Ohuchi, Hyun-Kyung Shin, Sam Rok Keum, Soon Sung Lim
Chem Pharm Bull 54(3):368. [CrossRef]
Mechanisms of Disease: adipocytokines and visceral adipose tissue—emerging role in intestinal and mesenteric diseases
Andreas Schäffler, Jürgen Schölmerich, Christa Büchler
Nat Clin Pract Gastroenterol Hepatol 2(2):103. [CrossRef]
Analysis of patent applications relating to peroxisome proliferator-activated receptor (PPAR) ligands in 2004
Hiroyuki Miyachi
eotp 15(11):1521. [CrossRef]
Long-term treatment with an angiotensin II receptor blocker decreases adipocyte size and improves insulin signaling in obese Zucker rats :
Marina C Muñoz, Jorge F Giani, Fernando P Dominici, Daniel Turyn, Jorge E Toblli
J Hypertens 27(12):2409. [CrossRef]
A novel dual peroxisome proliferator-activated receptors α and γ agonist with beneficial effects on insulin resistance and lipid metabolism
Cheng Xu, Li-Li Wang, Hong-Ying Liu, Cheng-Mai Ruan, Xing-Bo Zhou, Ying-Lin Cao, Song Li
Biotechnol Lett 28(12):863. [CrossRef]
Hirokazu Takahashi, Hitoshi Nakagama
Folia Pharmacol Jpn 128(4):231. [CrossRef]
Feeding Scallop Shell Powder Induces the Expression of Uncoupling Protein 1 (UCP1) in White Adipose Tissue of Rats
Yun Chun Liu, Keita Satoh, Yasushi Hasegawa
Biosci Biotechnol Biochem 70(11):2733. [CrossRef]
Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
Pascal Froment, Philippe Touraine
[CrossRef]
Ginsenoside 20(S)-Protopanaxatriol (PPT) Activates Peroxisome Proliferator-Activated Receptor γ (PPARγ) in 3T3-L1 Adipocytes
Kyu Lee Han, Myeong Ho Jung, Jong Hee Sohn, Jae-Kwan Hwang
Biol Pharm Bull 29(1):110. [CrossRef]
Effects of the Thiazolidinedione Medications on Micro- and Macrovascular Complications in Patients with Diabetes—Update 2008
Anand Rohatgi, Darren K. Mcguire
Cardiovasc Drugs Ther 22(3):233. [CrossRef]
Molecular Modeling and Structure-based Drug Discovery Studies of Aldose Reductase Inhibitors
Shuichi Miyamoto
CBIJ [CrossRef]
PPARγ2 Pro12Ala Polymorphism and Insulin Resistance in Japanese Hypertensive Patients
Junko Yamamoto, Shigeru Kageyama, Masami Nemoto, Takashi Sasaki, Tatsuya Sakurai, Ken-ichi Ishibashi, Akira Mimura, Kuninobu Yokota, Naoko Tajima
Hypertens Res 25(1):25. [CrossRef]
Laurent Gelman, Johan Auwerx
Curr Opin Clin Nutr Metab Care 2(4):307. [CrossRef]
Ectopic fat accumulation and metabolic syndrome
Neda Rasouli, Behzad Molavi, Steven C. Elbein, Philip A. Kern
Diabetes Obes Metab 9(1):1. [CrossRef]
Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?
Julien Becker, Carine Delayre-orthez, Nelly Frossard, Françoise Pons
Fundam Clin Pharmacol 20(5):429. [CrossRef]
Intake of conjugated eicosapentaenoic acid suppresses lipid accumulation in liver and epididymal adipose tissue in rats
Tsuyoshi Tsuzuki, Yuki Kawakami, Yoshihiro Suzuki, Renpei Abe, Kiyotaka Nakagawa, Teruo Miyazawa
Lipid 40(11):1117. [CrossRef]
Insulin Resistance, Adipocyte Biology, and Thiazolidinediones: A Review
Ozlem Tarcin, Mandeep Bajaj, Sema Akalin
metabolic syn rel disorders 5(2):103. [CrossRef]
Adiponectin and its response to thiazolidinediones are associated with insulin-mediated glucose metabolism in type 2 diabetic patients and their first-degree relatives
V. Hulstrøm, K. Højlund, J. Vinten, H. Beck-nielsen, K. Levin
Diabetes Obes Metab 10(11):1019. [CrossRef]
Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone
Leanne Wilson-fritch, Sarah Nicoloro, My Chouinard, Mitchell A. Lazar, Patricia C. Chui, John Leszyk, Juerg Straubhaar, Michael P. Czech, Silvia Corvera
J Clin Invest 114(9):1281. [CrossRef]
Effects of thiazolidinediones on blood pressure
Thomas D. Giles, Gary E. Sander
Current Science Inc 9(4):332. [CrossRef]
Insights into insulin resistance and type 2 diabetes from knockout mouse models
Takashi Kadowaki
J Clin Invest 106(4):459. [CrossRef]
Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice
Oksana Gavrilova, Bernice Marcus-samuels, David Graham, Jason K. Kim, Gerald I. Shulman, Arthur L. Castle, Charles Vinson, Michael Eckhaus, Marc L. Reitman
J Clin Invest 105(3):271. [CrossRef]
Inhibition of RXR and PPARγ ameliorates diet-induced obesity and type 2 diabetes
Toshimasa Yamauchi, Hironori Waki, Junji Kamon, Koji Murakami, Kiyoto Motojima, Kajuro Komeda, Hiroshi Miki, Naoto Kubota, Yasuo Terauchi, Atsuko Tsuchida
J Clin Invest 108(7):1001. [CrossRef]
Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones
Lily Chao, Bernice Marcus-samuels, Mark M. Mason, Jaideep Moitra, Charles Vinson, Elif Arioglu, Oksana Gavrilova, Marc L. Reitman
J Clin Invest 106(10):1221. [CrossRef]
Unraveling the mechanism of action of thiazolidinediones
C. Ronald Kahn, Lihong Chen, Shmuel E. Cohen
J Clin Invest 106(11):1305. [CrossRef]
PPARγ regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1
Patricia C. Chui, Hong-Ping Guan, Michael Lehrke, Mitchell A. Lazar
J Clin Invest 115(8):2244. [CrossRef]
Muscle-specific PPARγ-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones
Andrew W. Norris, Lihong Chen, Simon J. Fisher, Ildiko Szanto, Michael Ristow, Alison C. Jozsi, Michael F. Hirshman, Evan D. Rosen, Laurie J. Goodyear, Frank J. Gonzalez
J Clin Invest 112(4):608. [CrossRef]
Hepatic and Adipose Tissue Depot-Specific Changes in Lipid Metabolism in Late-Onset Obese (LOB) Rats
Fredrik Frick, Randip Hume, Iain C. Robinson, Staffan Edén, Jan Oscarsson
Lipid 43(4):313. [CrossRef]
Inhibitory Action of Troglitazone, an Insulin-Sensitizing Agent, on the Calcium Current in Cardiac Ventricular Cells of Guinea Pig.
Yoko Katoh, Shigeatsu Hashimoto, Junko Kimura, Tsuyoshi Watanabe
Jpn J Pharmacol 82(2):102. [CrossRef]
Mechanical stretching inhibits adipocyte differentiation of 3T3-L1 cells: the molecular mechanism and pharmacological regulation
Yoshiyuki Tanabe, Koichi Nakayama
Folia Pharmacol Jpn 124(5):337. [CrossRef]
Pleiotropic effects of thiazolidinediones
CV Rizos, EN Liberopoulos, DP Mikhailidis, MS Elisaf
Expert Opin Pharmacother 9(7):1087. [CrossRef]
Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor ? agonist, FK614, ameliorates insulin resistance in Zucker fatty rats
H. Minoura, S. Takeshita, C. Kimura, J. Hirosumi, S. Takakura, I. Kawamura, J. Seki, T. Manda, S. Mutoh
Diabetes Obes Metab 9(3):369. [CrossRef]
Peroxisome Proliferator-Activated Receptor γ (PPARγ) Suppresses Colonic Epithelial Cell Turnover and Colon Carcinogenesis Through Inhibition of the β-Catenin / T Cell Factor (TCF) Pathway
Toshio Fujisawa, Atsushi Nakajima, Nobutaka Fujisawa, Hirokazu Takahashi, Ikuko Ikeda, Ayako Tomimoto, Kyoko Yonemitsu, Noriko Nakajima, Chiho Kudo, Koichiro Wada
J Pharmacol Sci 106(4):627. [CrossRef]
Early Obesity and Age-Related Mimicry of Metabolic Syndrome in Female Mice with Sex Hormonal Imbalances*
M Ram Sairam, Min Wang, Natalia Danilovich, Danesh Javeshghani, Dusica Maysinger
Obesity (Silver Spring) 14(7):1142. [CrossRef]
Human Adenovirus 36 Induces Adiposity, Increases Insulin Sensitivity, and Alters Hypothalamic Monoamines in Rats*
Magdalena Pasarica, Andrew C. Shin, Minghuan Yu, Hui-Mei Ou yang, Miloni Rathod, K-L. Catherine Jen, Sheba Mohankumar, Puliyur S. Mohankumar, Nathan Markward, Nikhil V. Dhurandhar
Obesity (Silver Spring) 14(11):1905. [CrossRef]
Profiling Adipocytokine Secretion from Creeping Fat in Crohn's Disease
Gisela Paul, Andreas Sch??ffler, Markus Neumeier, Alois F??rst, Frauke Bataillle, Christa Buechler, Ulf M??ller-ladner, J??rgen Sch??lmerich, Gerhard Rogler, Hans Herfarth
Inflamm Bowel Dis 12(6):471. [CrossRef]
A Phase II Study of Troglitazone, an Activator of the PPAR?? Receptor, in Patients with Chemotherapy-Resistant Metastatic Colorectal Cancer
Matthew H. Kulke, George D. Demetri, Norman E. Sharpless, David P. Ryan, Ramesh Shivdasani, Jeffrey S. Clark, Bruce M. Spiegelman, Haesook Kim, Robert J. Mayer, Charles S. Fuchs
Cancer J 8(5):395. [CrossRef]
Intrahepatic insulin resistance in a murine model of steatohepatitis: effect of PPARγ agonist pioglitazone
Isabelle A Leclercq, Valérie A Lebrun, Peter Stärkel, Yves J Horsmans
Lab Invest 87(1):56. [CrossRef]
Fat and Beyond: The Diverse Biology of PPARγ
Peter Tontonoz, Bruce M. Spiegelman
Annu Rev Biochem 77(1):289. [CrossRef]
Physiological, Pharmacological, and Nutritional Regulation of Circulating Adiponectin Concentrations in Humans
Michael M. Swarbrick, Peter J. Havel
metabolic syn rel disorders 6(2):87. [CrossRef]
Effects of Pretreatment with Low-dose Metformin on Metabolic Parameters and Weight Gain by Pioglitazone in Japanese Patients with Type 2 Diabetes
Toshihide Kawai, Osamu Funae, Akira Shimada, Mitsuhisa Tabata, Takumi Hirata, Yoshihito Atsumi, Hiroshi Itoh
Intern Med 47(13):1181. [CrossRef]
Acarbose Treatment Increases Serum Total Adiponectin Levels in Patients with Type 2 Diabetes
Hiromi Ochiai, Hikari Ooka, Chiho Shida, Toshio Ishikawa, Daisuke Inoue, Ryo Okazaki
Endocr J 55(3):549. [CrossRef]
Improved glucose tolerance in mice receiving intraperitoneal transplantation of normal fat tissue
D. Konrad, A. Rudich, E. J. Schoenle
Diabetologica 50(4):833. [CrossRef]
Reduced Adiposity in ob/ob Mice following Total Body Irradiation and Bone Marrow Transplantation*
Vitaly Ablamunits, Stuart P. Weisberg, Jacob E. Lemieux, Terry P. Combs, Simon Klebanov
Obesity (Silver Spring) 15(6):1419. [CrossRef]
Role of stearoyl-CoA desaturases in obesity and the metabolic syndrome
H E Popeijus, W H M Saris, R P Mensink
Int J Obes 32(7):1076. [CrossRef]
Systematic review: adipose tissue, obesity and gastrointestinal diseases
B. J. John, S. Irukulla, A. M. Abulafi, D. Kumar, M. A. Mendall
Aliment Pharmacol Ther 23(11):1511. [CrossRef]
Prevention of nutritionally induced diabetes by rosiglitazone in the gerbilPsammomys obesus
Simona Hefetz, Ehud Ziv, Anne Jörns, Sigurd Lenzen, Eleazar Shafrir
Diabetes Metab Res Rev 22(2):139. [CrossRef]
PPAR agonists as direct modulators of the vessel wall in cardiovascular disease
Kevin W. Buchan, David G. Hassall
Med Res Rev 20(5):350. [CrossRef]
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AND METABOLIC DISEASE
Timothy M. Willson, Millard H. Lambert, Steven A. Kliewer
Annu Rev Biochem 70(1):341. [CrossRef]
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis
Kittichai Promrat, Glen Lutchman, Gabriel I. Uwaifo, Renee J. Freedman, Alejandro Soza, Theo Heller, Edward Doo, Marc Ghany, Ahalya Premkumar, Yoon Park
Hepatol 39(1):188. [CrossRef]
Pioglitazone
Stephanie Easthope, Dean M Robinson, John Waugh, Gillian M Keating, Greg L Plosker
Drug 66(1):85. [CrossRef]
A Comparison of Agents Used to Manage Type 2 Diabetes Mellitus
David S H Bell
Treat Endocrinol 3(2):67. [CrossRef]
Genetic Basis of Type 2 Diabetes Mellitus
Johanna K Wolford, Barbora Vozarova de courten
Treat Endocrinol 3(4):257. [CrossRef]
Current Views on the Mechanism of Action of Thiazolidinedione Insulin Sensitizers
Barry J. Goldstein
diabetes technol ther 1(3):267. [CrossRef]
Obesity Medications and the Treatment of Type 2 Diabetes
Frank Greenway
diabetes technol ther 1(3):277. [CrossRef]
Peroxisome Proliferator-Activated Receptor-??
Alper Kepez, Ali Oto, Selcuk Dagdelen
20(2):121. [CrossRef]
PPARgamma and the thiazolidinediones: molecular basis for a treatment of 'Syndrome X'?
C. Sewter, A. Vidal-puig
Diabetes Obes Metab 4(4):239. [CrossRef]
NEW ORAL THERAPIES FOR TYPE 2 DIABETES MELLITUS: The Glitazones or Insulin Sensitizers1
Sunder Mudaliar, Robert R. Henry
Ann Rev Med 52(1):239. [CrossRef]
Comparison of the effects of glimepiride and glibenclamide on adipose tissue tumour necrosis factor-alpha mRNA expression and cellularity
Y. Mori, H. Komiya, N. Kurokawa, N. Tajima
Diabetes Obes Metab 6(1):28. [CrossRef]
The brown adipose cell: a model for understanding the molecular mechanisms of insulin resistance
A. M. Valverde, M. Benito, M. Lorenzo
Acta Physiol Scand 183(1):59. [CrossRef]
NUCLEAR RECEPTORS AND THE CONTROL OF METABOLISM
Gordon A. Francis, Elisabeth Fayard, Frederic Picard, Johan Auwerx
Annu Rev Physiol 65(1):261. [CrossRef]
PPAR AND GLUCOSE HOMEOSTASIS
Frederic Picard, Johan Auwerx
Annu Rev Nutr 22(1):167. [CrossRef]
Effects Of Combined Pioglitazone And Metformin On Diabetes And Obesity In Wistar Fatty Rats
Masami Suzuki, Hiroyuki Odaka, Noriko Suzuki, Yasuo Sugiyama, Hitoshi Ikeda
Clin Exp Pharmacol Physiol 29(4):269. [CrossRef]
PPAR.GAMMA. agonist and antagonist.
Takashi Kadowaki
Folia Pharmacol Jpn 118(5):321. [CrossRef]
Troglitazone Ameliorates Abnormal Activity of Protein Tyrosine Phosphatase in Adipose Tissues of Otsuka Long-Evans Tokushima Fatty Rats.
SEIICHI Tagami, TOSHIRO Honda, HARUHIKO Yoshimura, HIDEAKI Homma, KOSEI Ohno, HAJIME Ide, SHINJI Sakaue, YOSHIKAZU Kawakami
Tohoku J Exp Med 197(3):169. [CrossRef]
Hypoglycemic Effects of Turmeric (Curcuma longa L. Rhizomes) on Genetically Diabetic KK-Ay Mice
Minpei Kuroda, Yoshihiro Mimaki, Tozo Nishiyama, Tatsumasa Mae, Hideyuki Kishida, Misuzu Tsukagawa, Kazuma Takahashi, Teruo Kawada, Kaku Nakagawa, Mikio Kitahara
Biol Pharm Bull 28(5):937. [CrossRef]
Novel insulin sensitizers: pharmacogenomic aspects
Carsten Otto, Michael Lehrke, Burkhard Goke
phgs 3(1):99. [CrossRef]
Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy
Edward D. Javor, Marc G. Ghany, Elaine K. Cochran, Elif Arioglu Oral, Alex M. Depaoli, Ahalya Premkumar, David E. Kleiner, Phillip Gorden
Hepatol 41(4):753. [CrossRef]
The mechanisms by which PPAR.GAMMA. and adiponectin regulate glucose and lipid metabolism.
Junji Kamon, Toshimasa Yamauchi, Yasuo Terauchi, Naoto Kubota, Takashi Kadowaki
Folia Pharmacol Jpn 122(4):294. [CrossRef]
The role of PPAR.GAMMA. in the onset of type 2 diabetes.
Kazuo Hara, Toshimasa Yamauchi, Naoto Kubota, Kazuyuki Tobe, Tsutomu Yamazaki, Ryozo Nagai, Takashi Kadowaki
Folia Pharmacol Jpn 122(4):317. [CrossRef]
Alteration in Expression Profiles of a Series of Diabetes-Related Genes in db/db Mice Following Treatment With Thiazolidinediones.
Akiko Suzuki, Toru Yasuno, Hitoshi Kojo, Jiro Hirosumi, Seitaro Mutoh, Yoshitada Notsu
Jpn J Pharmacol 84(2):113. [CrossRef]
Helene Duez, Jean-Charles Fruchart, Bart Staels
J Cardiovasc Risk 8(4):187. [CrossRef]
Satoshi Sunayama, Yoshiro Watanabe, Hiroyuki Daida, Hiroshi Yamaguchi
Curr Opin Lipidol 11(4):397. [CrossRef]
New therapeutic approaches to reversing insulin resistance :
Gabriele E. Sonnenberg, Theodore A. Kotchen
[CrossRef]
Evan Rosen, Bruce Spiegelman
CURR OPIN ENDOCRINOL DIABETES 6(2):170. [CrossRef]
Sunder Mudaliar, Robert Henry
CURR OPIN ENDOCRINOL DIABETES 9(4):285. [CrossRef]
Christian Weyer, Richard Pratley, P. Tataranni
CURR OPIN ENDOCRINOL DIABETES 9(2):130. [CrossRef]
Clinical evaluation of pioglitazone in patients with type 2 diabetes using alpha-glucosidase inhibitor and examination of its efficacy profile
Y. Hayashi, N. Miyachi, T. Takeuchi, Y. Takeuchi, F. Kamiya, T. Kato, K. Imaeda, N. Okayama, M. Shimizu, M. Itoh
Diabetes Obes Metab 5(1):58. [CrossRef]
Methionine restriction decreases visceral fat mass and preserves insulin action in aging male Fischer 344 rats independent of energy restriction
Virginia L. Malloy, Rozlyn A. Krajcik, Steven J. Bailey, George Hristopoulos, Jason D. Plummer, Norman Orentreich
5(4):305. [CrossRef]
C333H, a novel PPARalpha/gamma dual agonist, has beneficial effects on insulin resistance and lipid metabolism1
Cheng Xu, Li-li Wang, Hong-ying Liu, Xing-bo Zhou, Ying-lin Cao, Song Li
Acta Pharmacol Sin 27(2):223. [CrossRef]
Effects of astragaloside IV on pathogenesis of metabolic syndrome in vitro1
Ming-en Xu, Shang-zhi Xiao, Yong-hong Sun, Yang Ou-yang, Xiao-xiang Zheng
Acta Pharmacol Sin 27(2):229. [CrossRef]
Effect of short-term ACE inhibitor treatment on peripheral insulin sensitivity in obese insulin-resistant subjects
G. H. Goossens, E. E. Blaak, P. M. Schiffers, W. H. M. Saris, M. A. Baak
Diabetologica 49(12):3009. [CrossRef]
Fibrinolysis and diabetic vascular disease: roles of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor
Yoshimasa Aso
Future Lipidol 1(4):429. [CrossRef]
Impact of the renin-angiotensin system on lipid and carbohydrate metabolism
Pasquale Strazzullo, Ferruccio Galletti
13(3):325. [CrossRef]
Current and novel approaches to the drug therapy of obesity
Jean-Philippe Chaput, Angelo Tremblay
E J Clin Pharmacol 62(10):793. [CrossRef]
The periodontal host response with diabetes
Fusanori Nishimura, Yoshihiro Iwamoto, Yoshihiko Soga
Periodontol 2000 43(1):245. [CrossRef]
Insulin-sensitizing effects of a novel ?-methyl-?-phenoxylpropionate derivative in vitro
Hao-shu Wu, Juan-hong Yu, Ying-yin Li, Yu-she Yang, Qiao-jun He, Yi-jia Lou, Ru-yun Ji
Acta Pharmacol Sin 28(3):417. [CrossRef]
Dual PPAR ??/?? Agonists: Promises and Pitfalls in Type 2 Diabetes
Intekhab Ahmed, Kevin Furlong, Jeremy Flood, Vanita P Treat, Barry J Goldstein
Am J Ther 14(1):49. [CrossRef]
Fat cell enlargement is an independent marker of insulin resistance and ‘hyperleptinaemia’
M. Lundgren, M. Svensson, S. Lindmark, F. Renström, T. Ruge, J. W. Eriksson
Diabetologica 50(3):625. [CrossRef]
Absence of an adipogenic effect of rosiglitazone on mature 3T3-L1 adipocytes: increase of lipid catabolism and reduction of adipokine expression
P. Wang, J. Renes, F. Bouwman, A. Bunschoten, E. Mariman, J. Keijer
Diabetologica 50(3):654. [CrossRef]
Acute and selective regulation of glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase in adipose tissue by thiazolidinediones in type 2 diabetes
F. Fouque, G. D. Tan, E. Loizon, E. G. Beale, K. N. Frayn, F. Karpe, H. Vidal, T. Cadoudal, J. M. Blouin, M. Collinet
Diabetologica 50(3):666. [CrossRef]
Peroxisome proliferator-activated receptor-δ, a regulator of oxidative capacity, fuel switching and cholesterol transport
C. Fürnsinn, T. M. Willson, B. Brunmair
Diabetologica 50(1):8. [CrossRef]
Quantitative image analysis in adipose tissue using an automated image analysis system: Differential effects of peroxisome proliferator-activated receptor-? and -? agonist on white and brown adipose tissue morphology in AKR obese and db/db diabetic mice
Yuji Okamoto, Hiroyuki Higashiyama, Hiroki Inoue, Masahiro Kanematsu, Mine Kinoshita, Satoshi Asano
Pathol Int 57(6):369. [CrossRef]
Soy Protein and Isoflavones Influence Adiposity and Development of Metabolic Syndrome in the Obese Male ZDF Rat
Jeremy Davis, Allan Higginbotham, Timothy O’connor, Naima Moustaid-moussa, Adam Tebbe, Young-Cheul Kim, Kae Won Cho, Neil Shay, Stuart Adler, Richard Peterson
Ann Nutr Metab 51(1):42. [CrossRef]
PPAR ligands: Potential therapies for metabolic syndrome
Taro E. Akiyama, Peter T. Meinke, Joel P. Berger
Curr Diab Rep 5(1):45. [CrossRef]
Vascular signaling pathways in the metabolic syndrome
Hiromi Rakugi, Kei Kamide, Toshio Ogihara
Current Science Inc 4(2):105. [CrossRef]
Comparison of the effects of pioglitazone and voglibose on circulating total and high-molecular-weight adiponectin, and on two fibrinolysis inhibitors, in patients with Type�2 diabetes
Y. Aso, R. Yamamoto, M. Suetsugu, S. Matsumoto, S. Wakabayashi, R. Matsutomo, K. Takebayashi, T. Inukai
Diabetic Med 24(9):962. [CrossRef]
The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity
Francesco S. Celi, Alan R. Shuldiner
Curr Diab Rep 2(2):179. [CrossRef]
The effects of obesity-associated insulin resistance on mRNA expression of peroxisome proliferator-activated receptor-γ target genes, in dogs
Veronique Leray, Masayuki Saito, Brigitte Siliart, Patrick Nguyen, Constance Gayet
br j nutr 98(3):497. [CrossRef]
Telmisartan, An Angiotensin II Type 1 Receptor Blocker, Controls Progress of Nonalcoholic Steatohepatitis in Rats
Koji Fujita, Masato Yoneda, Koichiro Wada, Hironori Mawatari, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Yuichi Nozaki, Shiro Maeyama, Satoru Saito
Dig Dis Sci 52(12):3455. [CrossRef]
Adipose tissue expandability and the metabolic syndrome
Antonio J. Vidal-puig, Marc Slawik
Genes Nutr 2(1):41. [CrossRef]
Structure-Based Design and Synthesis of Fluorescent PPARα/δ Co-agonist and Its Application as a Probe for Fluorescent Polarization Assay of PPARδ Ligands
Yoko Araya, Jun-ichi Kasuga, Kenji Toyota, Yuko Hirakawa, Takuji Oyama, Makoto Makishima, Kosuke Morikawa, Yuichi Hashimoto, Hiroyuki Miyachi
Chem Pharm Bull 56(9):1357. [CrossRef]
Rosiglitazone Modulates Insulin-Induced Plasma Membrane Area Changes in Single 3T3-L1 Adipocytes
Jelena Velebit, Petra Brina Kovačič, Mateja Prebil, Helena H. Chowdhury, Sonja Grilc, Marko Kreft, Jørgen Jensen, Esma R. Isenović, Robert Zorec
J Membr Biol 223(3):141. [CrossRef]
Post-statin approaches to hyperlipidaemia
P Duriez, JC Fruchart
Expert Opin Invest Drugs 7(12):1997. [CrossRef]
Insights into Molecular Pathogenesis of Type 2 Diabetes from Knockout Mouse Models.
YASUO Terauchi, TAKASHI Kadowaki
Endocr J 49(3):247. [CrossRef]
Glucose-lowering effect of powder formulation of African black tea extract in KK-Ay/TaJcl diabetic mouse
Yoko Shoji, Hideki Nakashima
Arch Pharm Res 29(9):786. [CrossRef]
Effects of Dietary Korean Proso-Millet Protein on Plasma Adiponectin, HDL Cholesterol, Insulin Levels, and Gene Expression in Obese Type 2 Diabetic Mice
Kyung-Ok Park, Yoshiaki Ito, Takashi Nagasawa, Myeong-Rak Choi, Naoyuki Nishizawa
Biosci Biotechnol Biochem 72(11):2918. [CrossRef]
Aqueous Extract of Kotahla Himbutu (Salacia reticulata) Stems Promotes Oxygen Comsumption and Supresses Body Fat Accumulation in Mice
Ryanghyok Im, Hiroshi Mano, Sachie Nakatani, Jun Shimizu, Masahiro Wada
J Health Sci 54(6):645. [CrossRef]
Basal lipolysis, not the degree of insulin resistance, differentiates large from small isolated adipocytes in high-fat fed mice
S. Wueest, R. A. Rapold, J. M. Rytka, E. J. Schoenle, D. Konrad
Diabetologica 52(3):541. [CrossRef]
Thiazolidinediones: effects on insulin resistance and the cardiovascular system
C E Quinn, P K Hamilton, C J Lockhart, G E Mcveigh
Br J Pharmacol 153(4):636. [CrossRef]
Investigation of the Anti-Obesity Action of Licorice Flavonoid Oil in Diet-Induced Obese Rats
Hiroshi Kamisoyama, Kazuhisa Honda, Yuji Tominaga, Shinichi Yokota, Shin Hasegawa
Biosci Biotechnol Biochem 72(12):3225. [CrossRef]
The isoflavonoid aglycone-rich fractions of Chungkookjang, fermented unsalted soybeans, enhance insulin signaling and peroxisome proliferator-activated receptor-γ activity in vitro
Dae Young Kwon, Jin Sun Jang, Ji Eun Lee, Yong-Suk Kim, Dong-Hwa Shin, Sunmin Park
26(4):245. [CrossRef]
Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARα in high fat diet-induced obese mice
Sunhyo Jeong, Michung Yoon
Exp Mol Med 41(6):397. [CrossRef]
Bitter melon (Momordica charantia L.) inhibits adipocyte hypertrophy and down regulates lipogenic gene expression in adipose tissue of diet-induced obese rats
Hui-Ling Huang, Ya-Wen Hong, You-Hong Wong, Ying-Nien Chen, Jong-Ho Chyuan, Ching-Jang Huang, Pei-Min Chao
br j nutr [CrossRef]
New computed tomography-derived indices to predict cardiovascular and insulin-resistance risks in overweight/obese patients
C Piernas, J J Hernández-morante, M Canteras, S Zamora, M Garaulet
Eur J Clin Nutr 63(7):887. [CrossRef]
PPARγ Pro12Ala Pro/Pro and resistin SNP-420 G/G genotypes are synergistically associated with plasma resistin in the Japanese general population
Haruhiko Osawa, Yasuharu Tabara, Ryuichi Kawamoto, Jun Ohashi, Masaaki Ochi, Hiroshi Onuma, Wataru Nishida, Kazuya Yamada, Jun Nakura, Tetsuro Miki
Clin Endocrinol (Oxf) 71(3):341. [CrossRef]
Genetics, physiology and perinatal influences in childhood obesity: view from the Chair
G A Mitchell
Int J Obes [CrossRef]
